中國水務(00855.HK)建議發行優先票據
格隆匯 4 月 12日丨中國水務(00855.HK)發佈公吿,公司擬進行優先票據的國際發售。票據的定價(包括本金總額、發售價及利率)將根據票據發行的聯席全球協調人摩根士丹利、法國巴黎銀行及澳新銀行(連同東亞銀行有限公司及星展銀行有限公司為聯席賬簿管理人及聯席牽頭經辦人)所進行的累計投標結果而釐定。預期於落實票據的條款後,摩根士丹利、法國巴黎銀行、澳新銀行、東亞銀行有限公司、星展銀行有限公司、公司及附屬公司擔保人將會訂立購買協議。
公司擬根據公司的綠色融資框架將票據發行所得款項淨額用於為公司償還2017年票據及若干其他債務及用作營運資金。公司已收到新交所原則上批准票據於新交所上市及報價。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.